Profile

Vladimir Vladimirov

Professor | Member of the Graduate Faculty | Professor, Genetics - GIDP | Professor, Clinical Translational Sciences

Grants(4)

Publications(26)

Recent

Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information

2023

Integrative Post-Genome-Wide Association Study Analyses Relevant to Psychiatric Disorders: Imputing Transcriptome and Proteome Signals

2023

Repeated social defeat stress leads to immunometabolic shifts in innate immune cells of the spleen

2023

S100a9 Protects Against the Effects of Repeated Social Defeat Stress

2023

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 PD-1) inhibitor cetrelimab JNJ-63723283) in patients with advanced cancers

2022

Large-scale integration of DNA methylation and gene expression array platforms identifies both and relationships

2022

Long Non-Coding RNAs: The New Frontier into Understanding the Etiology of Alcohol Use Disorder

2022

DECO: a framework for jointly analyzing de novo and rare case/control variants, and biological pathways

2021

Identifying a novel biological mechanism for alcohol addiction associated with circRNA networks acting as potential miRNA sponges

2021

Gene Expression Differences Between Young Adults Based on Trauma History and Post-traumatic Stress Disorder

2021

People

Profile

Vladimir Vladimirov

Collaboration(3)

Zachary Taylor

Ayman Fanous

John Drake

Grants(4)

Publications(26)

Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information

Integrative Post-Genome-Wide Association Study Analyses Relevant to Psychiatric Disorders: Imputing Transcriptome and Proteome Signals

Repeated social defeat stress leads to immunometabolic shifts in innate immune cells of the spleen

S100a9 Protects Against the Effects of Repeated Social Defeat Stress

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 PD-1) inhibitor cetrelimab JNJ-63723283) in patients with advanced cancers

Large-scale integration of DNA methylation and gene expression array platforms identifies both and relationships

Long Non-Coding RNAs: The New Frontier into Understanding the Etiology of Alcohol Use Disorder

DECO: a framework for jointly analyzing de novo and rare case/control variants, and biological pathways

Identifying a novel biological mechanism for alcohol addiction associated with circRNA networks acting as potential miRNA sponges

Gene Expression Differences Between Young Adults Based on Trauma History and Post-traumatic Stress Disorder

Profile

Vladimir Vladimirov

Collaboration(3)

Zachary Taylor

Ayman Fanous

John Drake

Grants(4)

Publications(26)

Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information

Integrative Post-Genome-Wide Association Study Analyses Relevant to Psychiatric Disorders: Imputing Transcriptome and Proteome Signals

Repeated social defeat stress leads to immunometabolic shifts in innate immune cells of the spleen

S100a9 Protects Against the Effects of Repeated Social Defeat Stress

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 PD-1) inhibitor cetrelimab JNJ-63723283) in patients with advanced cancers

Large-scale integration of DNA methylation and gene expression array platforms identifies both and relationships

Long Non-Coding RNAs: The New Frontier into Understanding the Etiology of Alcohol Use Disorder

DECO: a framework for jointly analyzing de novo and rare case/control variants, and biological pathways

Identifying a novel biological mechanism for alcohol addiction associated with circRNA networks acting as potential miRNA sponges

Gene Expression Differences Between Young Adults Based on Trauma History and Post-traumatic Stress Disorder